Okasa Pharma Private Limited - Company Profile

It is a metals and minerals private limited company based in Mumbai-400 001.(Wef-27/8/2001), Maharashtra, India, established in 1990.
1990 Mumbai-400 001.(Wef-27/8/2001), Maharashtra, India Active
Last Updated:
Access Report
About Okasa Pharma Private Limited

Okasa Pharma Private Limited, a active private limited company, was established on 25 May 1990 in Mumbai-400 001.(Wef-27/8/2001), Maharashtra, India. Engaging in metal retail & distribution within the trade sector, it holds CIN: U24239MH1990PTC071153. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.50 Cr and a paid-up capital of ₹2.20 M.

It upholds a compliant status. Employing 1 professional, Its leadership includes Raman Parameswaran Athipotta (Director), Srinivas Hariharan (Director). Past directors included Vilas Gopal Khire, Raman Parameswaran Athipotta. It holds no open charges and ₹5.25 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 12 Gunbow Street,,Fort,Mumbai, Mumbai-400 001.(Wef-27/8/2001), Maharashtra, 400001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1990PTC071153

  • Registration Number

    071153

  • Incorporation Date

    25 May 1990

  • Authorized Capital

    ₹10.50 Cr

  • Paid-Up Capital

    ₹2.20 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.50 Cr
  • Paid Up Capital ₹ 2.20 M
  • Company Age 35 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 5.25 Cr
  • Revenue Growth **** -83.99%
  • Profit Growth **** 93.57%
  • Ebitda **** -5.20%
  • Net Worth -0.20%
  • Total Assets -0.20%
Company report

Okasa Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Okasa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Okasa Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Raman Parameswaran Athipotta Director 31 Jan 2015 Current
Srinivas Hariharan Director 04 Sep 2002 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 31 Jan 2015 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Okasa Pharma.

Okasa Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 83.99% decrease. The company also saw a substantial improvement in profitability, with a 93.57% increase in profit. The company's net worth dipped by a decrease of 0.2%.

Okasa Pharma revenue growth over time
Okasa Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -83.99%
*******
*******
*******
*******
Revenue from Operations
*******
 -100.00%
*******
*******
*******
*******
Total Assets
*******
 -0.20%
*******
*******
*******
*******
Profit or Loss
*******
 93.57%
*******
*******
*******
*******
Net Worth
*******
 -0.20%
*******
*******
*******
*******
EBITDA
*******
 -5.20%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Okasa Pharma?

In 2023, Okasa Pharma had a public holding of 13.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹52,500,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 3.75 Cr
  • The Saraswat Co Operative Bank Ltd : 1.50 Cr
Latest Charge Details
Date Lender Amount Status
16 Nov 2004 Axis Bank Limited ₹3.75 Cr Satisfied
04 Jan 1993 The Saraswat Co Operative Bank Ltd ₹1.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Okasa Pharma?

Okasa Pharma has a workforce of 1 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Okasa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Okasa Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Okasa Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Okasa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Okasa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Charges

    The activity A charge registered on 16 Nov 2004 via Charge ID 80002720 with Axis Bank Limited was fully satisfied on 16 May 2015. was completed.

  • Director Appointment

    The activity Raman Parameswaran Athipotta was appointed as a Director was appointed as a Director on 31 Jan 2015 & has been associated with this company since 11 years 25 days . was completed.

  • Charges

    A charge with Axis Bank Limited of Rs. 3.75 Cr registered on 16 Nov 2004 with Charge ID 80002720 was modified on 31 Mar 2006. was recorded as a recent event.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 3.75 Cr with Charge ID 80002720 was registered on 16 Nov 2004. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Okasa Pharma Private Limited?

The CIN of Okasa Pharma Private Limited is U24239MH1990PTC071153.

Where is Okasa Pharma Private Limited headquartered?

Okasa Pharma Private Limited is headquartered at 12 Gunbow Street,,Fort,Mumbai, Mumbai-400 001.(Wef-27/8/2001), Maharashtra, 400001.

When was Okasa Pharma Private Limited incorporated?

Okasa Pharma Private Limited was incorporated on 25 May 1990.

Who are the current directors of Okasa Pharma Private Limited?

The current directors of Okasa Pharma Private Limited are

What is the primary industry of Okasa Pharma Private Limited?

The primary industry of Okasa Pharma Private Limited is Trade.

Is Okasa Pharma Private Limited a listed company?

Okasa Pharma Private Limited is unlisted.

What is the capital structure of Okasa Pharma Private Limited?

The authorized capital of Okasa Pharma Private Limited is ₹10.50 Cr, and the paid-up capital is ₹2.20 M.

What is the compliance status of Okasa Pharma Private Limited?

The compliance status of Okasa Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available